SCHEMBL18196929

SCHEMBL18196929

CNCc1cn(S(=O)(=O)c2cccc(C(F)(F)F)c2)c(-c2ccc(F)cc2F)c1OC

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 8/20 0.37
▸ DDR1 Q08345 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ SCN9A Q15858 1/20 0.35
▸ ALOX15 P16050 2/20 0.35
▸ HTR6 P50406 3/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ CACNA1B Q00975 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20530240 0.99 RORC (0.37) RORCDDR1LMNATSHRKMT2A
SCHEMBL18196935 0.93 RORC (0.40) RORCDDR1LMNATSHRKMT2A
Hydrochloric Acid SCHEMBL18190939 0.92 RORC (0.39) RORCDDR1LMNATSHRKMT2A
SCHEMBL18196928 0.92 RORC (0.37) RORCDDR1HTR6
Hydrochloric Acid SCHEMBL20530236 0.91 RORC (0.37) RORCDDR1HTR6GAA
SCHEMBL18196930 0.91 ALDH1A1 (0.39) RORCLMNATSHRKMT2ANPSR1
Abeprazan SCHEMBL18196939 0.91 HTR6 (0.39) KMT2AHTR6MAPT
Abeprazan SCHEMBL29443418 0.91 HTR6 (0.39) KMT2AHTR6MAPT
Abeprazan SCHEMBL29719476 0.91 HTR6 (0.39) KMT2AHTR6MAPT
Hydrochloric Acid SCHEMBL20530210 0.90 ALDH1A1 (0.38) RORCLMNATSHRKMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197867-B1 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAE WOONG PHARMA (KR) 2018-11-14 — — EP claimed
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2018-10-16 — — US claimed
EP-3197867-B1 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAE WOONG PHARMA (KR) 2018-11-14 — — EP disclosed
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2018-10-16 — — US disclosed
WO-2016175555-A2 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-11-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same GIPR, GRPR, HTR3E RORC 305/4885DDR1 1328/4885LMNA 4810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback